Literature DB >> 11123067

Antiphospholipid antibodies and the endothelium.

B J Hunt1, M A Khamashta.   

Abstract

This article reviews current understanding of the relationship between antiphospholipid antibodies and the endothelium. In vitro antiphospholipid antibodies produce endothelial cell activation. Clinical data in this area are scanty and worthy of future research, which could lead to new therapies in the management of antiphospholipid syndrome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123067     DOI: 10.1007/s11926-000-0087-6

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  38 in total

Review 1.  Regulation of the thrombotic potential of atheroma.

Authors:  P Libby; F Mach; U Schönbeck; T Bourcier; M Aikawa
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

2.  Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression.

Authors:  J George; D Harats; B Gilburd; A Afek; Y Levy; J Schneiderman; I Barshack; J Kopolovic; Y Shoenfeld
Journal:  Circulation       Date:  1999-05-04       Impact factor: 29.690

3.  Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo.

Authors:  S S Pierangeli; M Colden-Stanfield; X Liu; J H Barker; G L Anderson; E N Harris
Journal:  Circulation       Date:  1999-04-20       Impact factor: 29.690

Review 4.  Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology.

Authors:  J S Pober
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

5.  In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.

Authors:  V Combes; A C Simon; G E Grau; D Arnoux; L Camoin; F Sabatier; M Mutin; M Sanmarco; J Sampol; F Dignat-George
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

Review 6.  Barriers to xenotransplantation.

Authors:  F H Bach; S C Robson; H Winkler; C Ferran; K M Stuhlmeier; C J Wrighton; W W Hancock
Journal:  Nat Med       Date:  1995-09       Impact factor: 53.440

Review 7.  Can graft endothelial cells initiate a host anti-graft immune response?

Authors:  J S Pober; C G Orosz; M L Rose; C O Savage
Journal:  Transplantation       Date:  1996-02-15       Impact factor: 4.939

8.  The involvement of beta2-glycoprotein I (beta2-GPI) in human and murine atherosclerosis.

Authors:  J George; Y Shoenfeld; D Harats
Journal:  J Autoimmun       Date:  1999-08       Impact factor: 7.094

9.  Transcriptional activation of the macrophage-colony stimulating factor gene by minimally modified LDL. Involvement of nuclear factor-kappa B.

Authors:  T B Rajavashisth; H Yamada; N K Mishra
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-10       Impact factor: 8.311

10.  Antiendothelial cell antibodies in patients with the antiphospholipid syndrome.

Authors:  R Cervera; M A Khamashta; J Font; G Ramírez; D D'Cruz; J Montalbán; A López-Soto; R A Asherson; M Ingelmo; G R Hughes
Journal:  Autoimmunity       Date:  1991       Impact factor: 2.815

View more
  3 in total

Review 1.  Sex differences in stroke: the contribution of coagulation.

Authors:  Meaghan Roy-O'Reilly; Louise D McCullough
Journal:  Exp Neurol       Date:  2014-02-19       Impact factor: 5.330

2.  Hypertensive disorders of pregnancy associated with adverse pregnant outcomes in patients with systemic lupus erythematosus: a multicenter retrospective study.

Authors:  Dongying Chen; Minxi Lao; Xiaoyan Cai; Hao Li; Yanfeng Zhan; Xiaodong Wang; Zhongping Zhan
Journal:  Clin Rheumatol       Date:  2019-08-03       Impact factor: 2.980

3.  PPARγ activation rescues mitochondrial function from inhibition of complex I and loss of PINK1.

Authors:  Juan Carlos Corona; Senio Campos de Souza; Michael R Duchen
Journal:  Exp Neurol       Date:  2013-12-26       Impact factor: 5.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.